Deutsche Bank’s Genomic Health, Inc. GHDX Stock Holding History

Deutsche Bank's GHDX Position: Q4 2019 in Review

Deutsche Bank sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 49,404 shares — an estimated $3.35M sold.

Deutsche Bank first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $41.2M in Q2 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

• Deutsche Bank reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
• Deutsche Bank sold 49,404 Genomic Health, Inc. shares in Q4 2019, an estimated $3.35M.
• Deutsche Bank first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
• Deutsche Bank's Genomic Health, Inc. position peaked at $41.2M in Q2 2019.
• 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Deutsche Bank's 13F filing for Q4 2019, filed 14 Feb 2020.